Sorry.
I just think studies are not very accurate, people need to have the right numbers, those can usually be found from FDA or individual doctor accounts. Studies regarding drugs safety on infliximab have always had very high conflict of interest because the only ones willing to pay for those studies have been the makers of the exact drugs they are testing.
All I hope is that no one takes the "safety of infliximab in 2000 patients over 2 years, sponsored by Jannsens" serious.
They might look like studies, but they're not studies, they're pamflets. They happen by doctors, they happen in hospitals, but they are not neutral.
It were individual doctors account who said to stop using combo therapy when possible, not studies. Studies said it was find and dandy, individual doctor accounts were titled "Is this what we're doing" after they lost patients.
Tysabri, same thing, studies said it was fine. Individual doctors said it was not fine and pulled on the alarm bell and told the FDA to remove it from the market.
It's these doctor accounts:
http://www.ncbi.nlm.nih.gov/pubmed?term=mixed%20fortunes%20crohn
titled "mixed fortunes" because they lost patients
Almost every study will say a drug is safe. Until a few months later the individual doctor accounts suddenly appear everywhere where they're losing patients. The FDA keeps records of those numbers and I think the picture of the FDA is fairly accurate, at least it's much better than studies sponsored by big pharma which show a completely one-sided picture, the FDA does a much better job.
I removed any ranking since I do not think it is a good idea, although I think people should make rankings.